Pulmonary Arterial Hypertension Pah clinical trials

Explore recruiting pulmonary arterial hypertension pah clinical trials.

Recruiting pulmonary arterial hypertension pah studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pulmonary Arterial Hypertension Pah trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension.

Spain, Poland, Italy, Belgium, Latvia, Denmark +8 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamic Effects of REGN13335, an Anti-PDGF-B Monoclonal Antibody, in Adults with Pulmonary Arterial Hypertension

Latvia, Belgium, France, Poland, Germany, Spain +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Investigate the Safety and Efficacy of KER-012 in Combination with Background Therapy in Adult Participants with Pulmonary Arterial Hypertension (TROPOS-Study)

Germany, Portugal, Poland, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002

Portugal, Italy, Sweden, Czechia, Ireland, France +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-label Extension Study to Evaluate the Safety and Tolerability of Sotatercept (MK-7962) Administered Using a Weight-banded Approach in Participants With Pulmonary Arterial Hypertension (PAH) on Standard of Care.

Italy, Czechia, France, Hungary, Netherlands, Poland +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

(15681) Open-label, individual dose titration study to evaluate safety, tolerability and pharmacokinetics of riociguat in children from 6 to less than 18 years of age with pulmonary arterial hypertension (PAH)

Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pulmonary Arterial Hypertension Pah trials by city

Pulmonary Arterial Hypertension Pah in Toronto Pulmonary Arterial Hypertension Pah in Vancouver Pulmonary Arterial Hypertension Pah in Montreal Pulmonary Arterial Hypertension Pah in Calgary Pulmonary Arterial Hypertension Pah in Edmonton Pulmonary Arterial Hypertension Pah in Ottawa Pulmonary Arterial Hypertension Pah in Winnipeg Pulmonary Arterial Hypertension Pah in Quebec City Pulmonary Arterial Hypertension Pah in Hamilton Pulmonary Arterial Hypertension Pah in Kitchener Pulmonary Arterial Hypertension Pah in London Pulmonary Arterial Hypertension Pah in Halifax Pulmonary Arterial Hypertension Pah in New York Pulmonary Arterial Hypertension Pah in Los Angeles Pulmonary Arterial Hypertension Pah in Chicago Pulmonary Arterial Hypertension Pah in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease